Chief Scientific Officer of Pace® Life Sciences Joins Industry Leaders at Advancing Drug Development Forum (ADDF) to Collaborate on Technologies for Non-Traditional Molecules

Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly volunteers, supporting its advancement into further clinical development for Alzheimer's and other neurodegenerative diseases.

Platinum Status Demonstrates Icreon's Unmatched Digital Experience Capabilities for Enterprise Clients

Strong data foundations and AI-driven insights help pharmaceutical and animal health companies deliver the right message to the right stakeholder, at the right time.

DistillerSR's literature review platform to provide turn-key integrated access to Embase' API, greatly enhancing and simplifying the review process

With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development.

A new report from the Franklin & Marshall's Center for Opinion Research and the Initiative for Medicines, Access & Knowledge (I-MAK) reveal Americans' top concerns on drug pricing.

Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.

• Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.

• High-quality biological patient data, enriched and integrated for use by AI agents.

Move positions company at the heart of Cambridge's innovation ecosystem to accelerate growth and collaboration in infection prevention.

Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution.

PeekDirect™ Delivers Transparent and Affordable Pricing for Brand and Specialty Drugs to Reduce Prescription Costs for Employers and Patients

Belhaven's Investigational New Drug (IND) Application Receives FDA Authorization to Proceed

Established healthcare leader expands into sports nutrition sector with comprehensive performance-focused product line

Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms

Company to attend upcoming NewYorkBIO Innovation Summit on September 30, 2025, in New York City

New Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity

Industry-recognized expert SciBite, and Pistoia Alliance Board Member, joins Rancho to advance structured data solutions for life sciences innovation

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum

Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions

Strategic leadership changes align with Canyon Labs' vision to scale services while strengthening its commitment to customer partnerships.

PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort)

Black Book Research Q2-Q3 proprietary surveys reveal digital health, cybersecurity, and data platforms as the foundation of pharma's future competitiveness

Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case.

Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies

Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule.

Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR.

Company commitment to quality excellence confirmed during FDA Inspection

Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships

New Arizona site represents Nutrishare's third pharmacy to support its ability to serve home TPN patients in all 50 states

Company Reopens State-of-the-Art Isolated Vial Filling Line at Aseptic Fill-Finish Center of Excellence

Vodori's app will deliver content access directly inside Salesforce, streamlining content approval-to-distribution workflows for life sciences teams seeking agility over complexity.

Explores Behemoth Labz GLP‑1 nasal formulation's structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic modeling.

Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs).

Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have achieved successful recent inspections

Leveraging Northway Biotech's 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma treatment

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable pharmacokinetic profile and high brain penetration. These findings support the advancement of SUL-238 into further clinical development for Alzheimer's and other neurodegenerative diseases.

• Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin

• Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action

Jeff Clark's Final Vision 2025 reveals expert-vetted tech stock picks in AI, biotech, and quantum computing-built on proven options strategies, chaos pattern analysis, and actionable investment timelines for serious traders seeking growth in a volatile market.

Dual siRNA Therapeutic Confirms Its Robust In Vivo Results, Strongly De-Risking the Clinical Path and Underscoring CCT-217's Potential as a Transformative, Patient-Friendly Therapy for Obesity and Metabolic Disorders

July 16 Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care

Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026.

This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies.